Hoth Therapeutics, Inc. — Director's Dealing 2025

Jan 15, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Hoth Therapeutics, Inc. (HOTH)
CIK: 0001711786
Period of Report: 2025-01-14

Reporting Person: Knie Robb (Director, CEO and President)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-01-14	Options	$1.55	A	93000	Acquired	2035-01-14	Common Stock (93000)	Direct
2025-01-14	Options	$1.55	A	7000	Acquired	2035-01-14	Common Stock (7000)	Direct

Footnotes

F1: The options were issued pursuant to the Issuer's 2018 Equity Incentive Plan, as amended, and vested in full upon grant.

F2: The options were issued pursuant to the Issuer's Amended and Restated 2022 Equity Incentive Plan, as amended, and vested in full upon grant.